Product NDC: | 67919-011 |
Proprietary Name: | Cubicin |
Non Proprietary Name: | Daptomycin |
Active Ingredient(s): | 500 mg/10mL & nbsp; Daptomycin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67919-011 |
Labeler Name: | Cubist Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021572 |
Marketing Category: | NDA |
Start Marketing Date: | 20030912 |
Package NDC: | 67919-011-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (67919-011-01) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Code | 67919-011-01 |
Proprietary Name | Cubicin |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (67919-011-01) > 10 mL in 1 VIAL, SINGLE-USE |
Product NDC | 67919-011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Daptomycin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20030912 |
Marketing Category Name | NDA |
Labeler Name | Cubist Pharmaceuticals, Inc. |
Substance Name | DAPTOMYCIN |
Strength Number | 500 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient] |